
Sclerosteosis and van Buchem disease are two rare bone sclerosing dysplasias caused by genetic defects in the synthesis of sclerostin. In this article we review the demographic, clinical, biochemical, radiological, and histological characteristics of patients with sclerosteosis and van Buchem disease that led to a better understanding of the role of sclerostin in bone metabolism in humans and we discuss the relevance of these findings for the development of new therapeutics for the treatment of patients with osteoporosis.
Van Buchem disease, Genetic Markers, Sclerostin, Bone resorption, Hyperostosis, Osteochondrodysplasias, Bone and Bones, Bone Density, Bone formation, Bone Morphogenetic Proteins, Humans, Syndactyly, Sclerosteosis, Biomarkers, Adaptor Proteins, Signal Transducing
Van Buchem disease, Genetic Markers, Sclerostin, Bone resorption, Hyperostosis, Osteochondrodysplasias, Bone and Bones, Bone Density, Bone formation, Bone Morphogenetic Proteins, Humans, Syndactyly, Sclerosteosis, Biomarkers, Adaptor Proteins, Signal Transducing
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 83 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 1% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
